AiM Medical Robotics Announces New Leadership Appointment
AiM Medical Robotics Inc. (AiM), a prominent developer of MRI-compatible intraoperative robotics for neurosurgery, has announced the election of Julie G. Pilitsis, MD, PhD, MBA, as the President of the American Society for Stereotactic and Functional Neurosurgery (ASSFN). Dr. Pilitsis, who is also a co-founder of AiM Medical Robotics and serves as the Chair of its Medical Advisory Board, has made significant contributions to neurosurgery. Her appointment to this esteemed position underscores her dedication to enhancing surgical precision and improving patient outcomes through cutting-edge technology.
Dr. Pilitsis’s Background and Expertise
Dr. Pilitsis is a Professor and Chair of the Department of Neurosurgery at the University of Arizona College of Medicine – Tucson, and she holds the role of Physician Executive for Functional Neurosurgery at Banner Health System. Since joining ASSFN in 2008, she has played a vital role in guiding the society's initiatives through her leadership on several committees, including the mentorship committee for fellows and residents. Her new position as President of ASSFN further cements her influence in the neurosurgery community.
Innovative Contributions to Neurosurgery
“As a neurosurgeon dedicated to enhancing patient care, I am thrilled about my collaboration with Dr. Gregory Fischer to develop MRI precision-guided robotics. We are preparing to launch our first patient study at Brigham and Women’s Hospital this fall,” Dr. Pilitsis stated.
Gregory Fischer, PhD, co-founder and CEO of AiM Medical Robotics, remarked, “Julie’s involvement with AiM has seamlessly integrated surgical planning into the system design, creating a workflow-friendly head frame robot. This innovation is set to increase precision and significantly reduce procedure times, which are critical needs in today’s neurosurgery profession.”
Advancements in Surgical Robotics
AiM Medical Robotics is set to introduce a compact, portable, MRI-compatible surgical robot that enhances intraoperative surgical planning and guidance through real-time soft tissue imaging. This groundbreaking technology is essential for addressing the challenges of brain shift, which can lead to inconsistent and less-than-optimal outcomes when the target shifts in relation to the skull during surgery. By incorporating MRI-guided robotics into standard procedures, AiM aims to improve hospital efficiency, procedural consistency, and patient outcomes.
Future Directions for AiM Medical Robotics
“Dr. Pilitsis’s election as President of ASSFN highlights her exceptional leadership and expertise in neurosurgery,” said Gregory Fischer, PhD. “Working with Julie for over 15 years has been a rewarding experience as we have refined practical strategies to utilize real-time MR imaging and robotics, optimizing this platform into a device that surgeons will eagerly adopt. Her contributions to AiM since its inception illustrate the future of neurosurgery, where technology and innovation come together to enhance patient care. We are proud to have her as a co-inventor and leader in our mission to transform neurosurgical practices.”
About AiM Medical Robotics
AiM Medical Robotics is a privately held medical device company dedicated to developing advanced, MRI-compatible robotics for neurosurgery. Our innovative surgical robots support intelligent intraoperative planning and real-time soft tissue imaging, addressing significant market challenges related to the efficient, accurate, and safe intracranial placement of neuromodulation, ablation, and drug delivery devices.
Frequently Asked Questions
Who has been elected as the President of ASSFN?
Dr. Julie G. Pilitsis, co-founder of AiM Medical Robotics, has been elected as the President of the American Society for Stereotactic and Functional Neurosurgery.
What is the primary focus of AiM Medical Robotics?
AiM Medical Robotics is focused on developing MRI-compatible intraoperative robotics to enhance surgical precision and improve patient outcomes in neurosurgery.
What technologies are being developed by AiM Medical Robotics?
AiM is developing a compact, portable surgical robot that facilitates intelligent intraoperative planning and real-time soft tissue imaging.
Who is the CEO of AiM Medical Robotics?
Gregory Fischer, PhD, is the co-founder and CEO of AiM Medical Robotics.
What issues does AiM's technology aim to address in surgery?
AiM's technology addresses the challenges related to brain shift during neurosurgical procedures, aiming for improved procedural consistency and outcomes.
